Zobrazeno 1 - 10
of 26
pro vyhledávání: '"Ximena Espejo Arce"'
Autor:
Ellen Hardy, Graciana Alves Duarte, Maria José Duarte Osis, Ximena Espejo Arce, Magali Possan
Publikováno v:
Cadernos de Saúde Pública, Vol 17, Iss 4, Pp 1031-1035 (2001)
Realizou-se um estudo multicêntrico (Brasil, Chile e México), qualitativo, para avaliar a aceitabilidade da anticoncepção de emergência entre potenciais usuárias, possíveis provedores, autoridades e outras pessoas influentes, e identificar, de
Externí odkaz:
https://doaj.org/article/3f4eb330fc4a48b2a949f4f42a31faa9
Autor:
Ellen Hardy, Graciana Alves Duarte, Maria José Duarte Osis, Ximena Espejo Arce, Magali Possan
Publikováno v:
Cadernos de Saúde Pública, Vol 17, Iss 4, Pp 1031-1035
Realizou-se um estudo multicêntrico (Brasil, Chile e México), qualitativo, para avaliar a aceitabilidade da anticoncepção de emergência entre potenciais usuárias, possíveis provedores, autoridades e outras pessoas influentes, e identificar, de
Externí odkaz:
https://doaj.org/article/69e9bd596a5a4aa38792a52981161509
Autor:
Fabiana C.Q.S. Anjos, Ana C. Marcelino, Ximena Espejo-Arce, Paula da C. Pereira, Priscila F. Barbosa, Cassia T. Juliato, Luis Bahamondes
Publikováno v:
Contraception. 122:109997
Autor:
Alejandra García Becerra, Montas Laporte, Ximena Espejo-Arce, Nelio Veiga, Luis Bahamondes, Lester Castro
Publikováno v:
International Journal of Gynecology & Obstetrics. 152:196-201
Objective We evaluated clinical performance when the TCu380A intrauterine device (IUD) and the levonorgestrel (LNG) 52-mg intrauterine system (IUS) were inserted by different categories of healthcare professionals. Methods A retrospective study was c
Autor:
Ilza Monteiro, Bianca Emanuelle Bevilaqua Franceschina, Sara Castro, Maria Margarete Hidalgo, Elaine A. L. Garcia, Ximena Espejo-Arce
Publikováno v:
Resumos do....
O sangramento uterino anormal (SUA), ou menorragia, e definido como qualquer perda anormal de sangue de origem uterina, descartando afeccoes orgânicas demonstraveis do trato genital e gravidez. Como disturbio frequente em qualquer epoca do periodo r
Autor:
Luis Bahamondes, Vinicius Machado Correia, Ilza Monteiro, Maria Helena de Sousa, Bruna F. Bottura, M. Valeria Bahamondes, Arlete Fernandes, Mayara P. Gonçalves, Ximena Espejo-Arce
Publikováno v:
Human Reproduction. 29:2163-2170
STUDY QUESTION: What is the contribution of the provision at no cost for users of long acting reversible contraceptive methods (LARC; copper intrauterine device [IUD] the levonorgestrel-releasing intrauterine system [LNG-IUS] contraceptive implants a
Publikováno v:
Human reproduction (Oxford, England). 30(8)
STUDY QUESTION: Is pretreatment with misoprostol useful in insertion of intrauterine contraceptives (IUCs) after insertion failure at the first attempt? SUMMARY ANSWER: Pretreatment with intravaginal administration of 200 mcg of misoprostol after IUC
Autor:
Luis Bahamondes, Maria Margarete Hidalgo, Cassia Teatin Juliato, Claudio Lisondo, Ximena Espejo-Arce, Ilza Monteiro
Publikováno v:
Contraception. 73:532-536
Objective To evaluate the prevalence of ovarian cysts in users of two contraceptive implants compared to users of intrauterine contraceptive (IUC). Materials and Methods A total of 344 women were enrolled at 3 months of use of the etonogestrel-releas
Autor:
Carlos Alberto Petta, Luis Bahamondes, Cassia Raquel Teatin-Juliato, Maria Margarete Hidalgo, Ximena Espejo-Arce, Creusa Hidalgo-Regina
Publikováno v:
Human Reproduction. 21:1316-1319
BACKGROUND: There are concerns about the effect of hormonal contraceptives on bone mineral density (BMD), but there is currently no information available on the effect of the levonorgestrel-releasing intrauterine system (LNGIUS) on BMD. The objective
Autor:
Luis Bahamondes, Jeffrey F. Lui-Filho, Marcos Perrotti, Carlos Alberto Petta, Ximena Espejo-Arce, Cecilia Monteiro-Dantas, Arlete Fernandes
Publikováno v:
Human Reproduction. 21:466-470
BACKGROUND: The aim of the study was to compare bone mineral density (BMD) before insertion and at 18 months of use of etonorgestrel- and levonorgestrel-releasing contraceptive implants. METHODS: One hundred and eleven women, 19–43 years of age, we